NCT02604537View on ClinicalTrials.gov

Betamethasone Versus Ketorolac Injection for the Treatment of DeQuervains Tenosynovitis

PHASE4CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

October 15, 2015

Primary Completion Date

October 1, 2024

Study Completion Date

October 30, 2024

Conditions
DeQuervain Tendinopathy
Interventions
DRUG

betamethasone

1 cc of 1% lidocaine (without epinephrine) plus 1 cc of 6 mg/ml betamethasone

DRUG

Ketorolac

1 cc of 1% lidocaine (without epinephrine) plus 1 cc of 30 mg/ml of ketorolac

Trial Locations (1)

28207

OrthoCarolina, Charlotte

All Listed Sponsors
lead

OrthoCarolina Research Institute, Inc.

OTHER

NCT02604537 - Betamethasone Versus Ketorolac Injection for the Treatment of DeQuervains Tenosynovitis | Biotech Hunter | Biotech Hunter